Doctor profile · Federal record
Dr. Nathalie Salafranca, APRN
Nurse Practitioner · Registered Nurse · Henderson, NV
- NPI 1609534502
- 5 yrs on file
- Female
- Solo practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
709 Taliput Palm Pl
Henderson, NV 890112629
(702) 275-9425 - Additional location
-
2850 W Horizon Ridge Pkwy Ste 140
Henderson, NV 890524395
(805) 719-3700
fax (805) 413-9099 - Additional location
-
7730 W Cheyenne Ave Ste 104
Las Vegas, NV 891298411
(805) 719-3700
fax (805) 413-9099
Credentials & registration
- NPI registered
- December 2021 — 5 yrs on file
- Profile last updated
- April 5, 2022
- Specialty taxonomy
- 363L00000X — NUCC code
- State licenses (2)
- Nevada #848923 · Nevada #RN74808
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1609534502. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
15,364
Distinct HCPCS
4
Medicare allowed
$193,756
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1306 |
Injection, inclisiran, 1 mg | 14,200 | 44 | $12 | |
J0897 |
Injection, denosumab, 1 mg | 1,020 | 16 | $23 | |
96372 |
Injection of drug or substance under skin or into muscle | 116 | 73 | $12 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 28 | 12 | $54 |
In context: peer comparison
Among 24 peers in this city , average services per provider: 297. This provider delivers 52× the peer median.Frequently asked questions
What is Dr. Nathalie Salafranca's medical specialty?
Dr. Nathalie Salafranca practices Nurse Practitioner in Henderson, NV.
Where does Dr. Nathalie Salafranca practice?
Dr. Nathalie Salafranca practices at 709 Taliput Palm Pl, Henderson, NV 890112629. Office phone: 7022759425.
What is Dr. Nathalie Salafranca's NPI?
Dr. Nathalie Salafranca's National Provider Identifier (NPI) is 1609534502, issued by NPPES.
What procedures does Dr. Nathalie Salafranca commonly perform?
Top Medicare-reported procedures in 2023: Injection, inclisiran, 1 mg (HCPCS J1306); Injection, denosumab, 1 mg (HCPCS J0897); Injection of drug or substance under skin or into muscle (HCPCS 96372). Source: CMS Medicare Physician & Other Practitioners file.